Biological Dynamics is a diagnostic company looking to revolutionize early detection of high burden diseases. Early detection is a high priority for cancer, as most cancer patients are currently diagnosed too late. The goal is to detect the early stages of cancer before it starts to spread. Biological Dynamics’ approach is to detect multi-omic biomarkers, such as exosomes and cell-free DNA, in blood by using their proprietary Verita platform. Verita is a lab-on-a-chip platform that isolates nanoparticles and macromolecules from biofluids reducing sample preparation and manipulation time. By combining Verita-powered multi-omic analyses with advanced machine learning algorithms, Biological Dynamics hopes to develop commercially viable diagnostic testing not just for cancer but also for neuroscience and infectious diseases.